Drugs in the Pipeline
Imbruvica Under Review for Graft-Versus-Host-Disease
Imbruvica is a first-in-class, oral Bruton's tyrosine kinase (BTK) inhibitor.
Your search for oral corticosteroids returned 3 results
Drugs in the Pipeline
Rituxan Gets Breakthrough Therapy Status for Rare Autoimmune Skin Disorder
Genentech announced that the Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to Rituxan (rituximab) for the treatment of pemphigus vulgaris.
Drugs in the Pipeline
Novel Asthma Biologic Demonstrates Efficacy in Two Phase 3 Studies
AstraZeneca announced that two pivotal Phase 3 registrational trials for benralizumab achieved their primary endpoint, demonstrating significant reductions in the annual asthma exacerbation rate compared to placebo.
